Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.

Benjamin N SchmeusserHenry BiermannEdouard H NicaiseAdil A AliDattatraya H PatilEric MidenbergTalia HelmanManuel Armas-PhanReza NabavizadehShreyas S JoshiVikram M NarayanMehmet A BilenSarah P PsutkaKenneth OganViraj A Master

Published in: The oncologist (2023)

Lower Cr/Cys-C is associated with inferior oncologic outcomes in RCC and, pending validation, may have utility as a serum biomarker for the presence of sarcopenia in patients with RCC treated with nephrectomy.

Keyphrases

renal cell carcinoma
prognostic factors
robot assisted
skeletal muscle
community dwelling
rectal cancer
uric acid
study protocol
prostate cancer
radical prostatectomy
clinical trial
adipose tissue
glycemic control
double blind